A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer

Clinical trial NCT00069875 · COMPLETED

Trial details

NCT number: NCT00069875
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2003-09-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.